腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體
Polyclonal Antibody to Meningioma Expressed Antigen 5 (MGEA5)
NAGase; MEA5; NCOAT; Hexosaminidase C; N-Acetylhexosaminidase; Hyaluronidase; Meningioma-Expressed Antigen 5; Nuclear Cytoplasmic O-GlcNAcase And Acetyltransferase
- 編號(hào)PAA069Hu03
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPA069Hu03-腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液(pH7.4,containing 0.05% Proclin-300,50% glycerol)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù),請(qǐng)參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 589 ¥ 1373 ¥ 1962 ¥ 4905 ¥ 19620
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對(duì)MGEA5的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別MGEA5。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
贈(zèng)品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對(duì)照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長(zhǎng)臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPA069Hu03 | 腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA069Hu01 | 腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA069Hu02 | 腦膜瘤表達(dá)抗原5(MGEA5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAA069Hu03 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | WB; IHC; ICC; IP. |
PAA069Hu01 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | WB,IHC,ICC/IF |
PAA069Hu02 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | WB; IHC; ICC; IP. |
FAA069Hu01 | 抗腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體 | Flow cytometry. |
LAA069Hu71 | 腦膜瘤表達(dá)抗原5(MGEA5)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
MAA069Hu22 | 腦膜瘤表達(dá)抗原5(MGEA5)單克隆抗體 | WB; IHC; ICC; IP. |
SEA069Hu | 腦膜瘤表達(dá)抗原5(MGEA5)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
SCA069Hu | 腦膜瘤表達(dá)抗原5(MGEA5)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA069Hu | 腦膜瘤表達(dá)抗原5(MGEA5)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Plos one | Metal-on-Metal Hip Prostheses and Systemic Health: A Cross-Sectional Association Study 8 Years after Implantation [PubMed: PMC3677913] |
Renal Failure | Evaluation of the Process of Recycling and Renal Parenchymal Injury after ESWL with Metabolites Excreted in the Urine [Pubmed: 23413820] |
BioMed Research International | The Renal Effects of Vanadate Exposure: Potential Biomarkers and Oxidative Stress as a Mechanism of Functional Renal Disorders—Preliminary Studies [Hindawi: 740105] |
PLoS One | Ameliorative Effect of Chrysin on Adenine-Induced Chronic Kidney Disease in Rats [PubMed: 25909514] |
Ecotoxicol Environ Saf | Melamine and oxalate coexposure induces early kidney tubular injury through mitochondrial aberrations and oxidative stress [34507040] |
Antioxidants | Diminishment of Nrf2 Antioxidative Defense Aggravates Nephrotoxicity of Melamine and Oxalate Coexposure. Antioxidants 2021, 10, 1464 [34573096] |